PNC Financial Services Group’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $863K | Buy |
10,578
+7,450
| +238% | +$538K | ﹤0.01% | 1471 |
|
|
2026
Q1 | $213K | Buy |
3,128
+244
| +8% | +$17.3K | ﹤0.01% | 2276 |
|
|
2025
Q4 | $219K | Buy |
2,884
+1,952
| +209% | +$142K | ﹤0.01% | 2243 |
|
|
2025
Q3 | $57.2K | Sell |
932
-63
| -6% | -$3.28K | ﹤0.01% | 3129 |
|
|
2025
Q2 | $48.6K | Buy |
995
+295
| +42% | +$14K | ﹤0.01% | 3133 |
|
|
2025
Q1 | $35.7K | Buy |
700
+320
| +84% | +$16K | ﹤0.01% | 3274 |
|
|
2024
Q4 | $17.2K | Buy |
380
+158
| +71% | +$6.76K | ﹤0.01% | 3602 |
|
|
2024
Q3 | $8.24K | Sell |
222
-42
| -16% | -$1.41K | ﹤0.01% | 3865 |
|
|
2024
Q2 | $8.07K | Buy |
264
+250
| +1,786% | +$8.1K | ﹤0.01% | 3846 |
|
|
2024
Q1 | $407 | Hold |
14
| – | – | ﹤0.01% | 4519 |
|
|
2023
Q4 | $386 | Buy |
+14
| New | +$320 | ﹤0.01% | 4440 |
|
|
2023
Q3 | – | Sell |
-76
| Closed | -$3.09K | – | 4717 |
|
|
2023
Q2 | $3.09K | Buy |
+76
| New | +$3.72K | ﹤0.01% | 4245 |
|
|
2022
Q2 | – | Sell |
-518
| Closed | -$19K | – | 4669 |
|
|
2022
Q1 | $19K | Buy |
518
+508
| +5,080% | +$19.6K | ﹤0.01% | 3603 |
|
|
2021
Q4 | $0 | Sell |
10
-8
| -44% | -$306 | ﹤0.01% | 4587 |
|
|
2021
Q3 | $1K | Buy |
18
+10
| +125% | +$411 | ﹤0.01% | 4217 |
|
|
2021
Q2 | $0 | Buy |
8
+2
| +33% | +$86 | ﹤0.01% | 4265 |
|
|
2021
Q1 | $0 | Sell |
6
-5
| -45% | -$297 | ﹤0.01% | 4189 |
|
|
2020
Q4 | $1K | Hold |
11
| – | – | ﹤0.01% | 3916 |
|
|
2020
Q3 | $1K | Sell |
11
-12
| -52% | -$591 | ﹤0.01% | 3877 |
|
|
2020
Q2 | $1K | Hold |
23
| – | – | ﹤0.01% | 3860 |
|
|
2020
Q1 | $1K | Buy |
23
+10
| +77% | +$503 | ﹤0.01% | 3827 |
|
|
2019
Q4 | $1K | Buy |
13
+8
| +160% | +$340 | ﹤0.01% | 3902 |
|
|
2019
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4085 |
|
|
2019
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 4111 |
|
|
2019
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 4112 |
|
|
2018
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 4151 |
|
|
2018
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4214 |
|
|
2018
Q2 | $0 | Buy |
+5
| New | +$156 | ﹤0.01% | 4243 |
|
|
2016
Q3 | – | Sell |
-194
| Closed | -$1K | – | 4216 |
|
|
2016
Q2 | $1K | Sell |
194
-7
| -3% | -$51 | ﹤0.01% | 4370 |
|
|
2016
Q1 | $1K | Sell |
201
-5,373
| -96% | -$93.3K | ﹤0.01% | 4381 |
|
|
2015
Q4 | $180K | Buy |
5,574
+1,260
| +29% | +$37.1K | ﹤0.01% | 2144 |
|
|
2015
Q3 | $115K | Sell |
4,314
-3,674
| -46% | -$157K | ﹤0.01% | 2448 |
|
|
2015
Q2 | $385K | Buy |
7,988
+968
| +14% | +$56.5K | ﹤0.01% | 1802 |
|
|
2015
Q1 | $428K | Hold |
7,020
| – | – | ﹤0.01% | 1739 |
|
|
2014
Q4 | $364K | Sell |
7,020
-700
| -9% | -$30.8K | ﹤0.01% | 1720 |
|
|
2014
Q3 | $340K | Hold |
7,720
| – | – | ﹤0.01% | 1688 |
|
|
2014
Q2 | $202K | Buy |
7,720
+2,520
| +48% | +$53.9K | ﹤0.01% | 1924 |
|
|
2014
Q1 | $136K | Buy |
+5,200
| New | +$140K | ﹤0.01% | 2075 |
|
Other funds holding PTCT
RI
JT
PNC Financial Services Group's PTCT Position: Q2 2026 in Review
PNC Financial Services Group increased its PTC Therapeutics (PTCT) stake by 238% in Q2 2026, buying an estimated $538K and bringing the position to 10,578 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.
PNC Financial Services Group first reported a position in PTCT in Q1 2014 and has held it in 38 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- PNC Financial Services Group held 10,578 shares of PTC Therapeutics worth $863K as of Q2 2026.
- PNC Financial Services Group bought 7,450 PTC Therapeutics shares in Q2 2026, an estimated $538K.
- PTC Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1471 holding.
- PNC Financial Services Group first reported a position in PTC Therapeutics in Q1 2014 and has held it in 38 quarters since.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.